Keyphrases
Acute Decompensated Heart Failure
35%
Adaptive Servo-ventilation
11%
Arginine Vasopressin
8%
Atrial Fibrillation
17%
B-type Natriuretic Peptide
13%
Beta-blockers
12%
Bosentan
8%
Cardiac Resynchronization Therapy
9%
Cardiogenic Shock
12%
Catheter Ablation
12%
Chronic Kidney Disease
11%
Clinical Outcomes
9%
Combination Therapy
9%
Confidence Interval
11%
Congestive Heart Failure
14%
Continuous-flow Left Ventricular Assist Device (CF-LVAD)
11%
Device Implantation
14%
Heart Failure
38%
Heart Failure Hospitalization
8%
Heart Failure Patients
26%
Heart Failure with Preserved Ejection Fraction (HFpEF)
13%
Heart Rate
18%
Heart Transplantation
26%
Impella
20%
Implantable Left Ventricular Assist Device
8%
Ivabradine
8%
Japan
32%
Japanese Patients
11%
Left Ventricular Assist Device
37%
Left Ventricular Assist Device Implantation
25%
Left Ventricular Assist Device Support
10%
Left Ventricular Ejection Fraction
14%
Left Ventricular Remodeling
11%
Odds Ratio
8%
Older Men
9%
Patients with Heart Failure
39%
Prognostic Impact
13%
Pulmonary Arterial Hypertension
10%
Remote Dielectric Sensing
18%
Severe Aortic Stenosis
10%
Sodium Zirconium Cyclosilicate
8%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
9%
Stage D Heart Failure
12%
Systolic Heart Failure
11%
Therapeutic Strategies
14%
Tolvaptan
43%
Transcatheter Aortic Valve Implantation
11%
Transcatheter Aortic Valve Replacement
17%
Ventricular Assist Device
20%
Ventricular Myocytes
11%
Medicine and Dentistry
Ablation
12%
Adverse Event
8%
Aortic Insufficiency
8%
Aortic Stenosis
11%
Aortic Valve
7%
Aquaporin 2
7%
Argipressin
6%
Assisted Circulation
12%
Atrial Fibrillation
18%
Brain Natriuretic Peptide
17%
Cardiac Resynchronization Therapy
9%
Cardiogenic Shock
13%
Cardiovascular System
7%
Chronic Kidney Disease
9%
Combination Therapy
16%
Congestive Heart Failure
97%
Decompensated Heart Failure
7%
Dilated Cardiomyopathy
7%
Drug Therapy
6%
Ejection Fraction
8%
Everolimus
6%
Hazard Ratio
7%
Heart Failure with Preserved Ejection Fraction
6%
Heart Graft
6%
Heart Left Ventricle Ejection Fraction
13%
Heart Output
6%
Heart Transplantation
27%
Hemodynamic
21%
Hyperkalemia
6%
Hyponatremia
6%
Ivabradine
8%
Kidney Function
6%
Left Ventricle
6%
Left Ventricular Assist Device
70%
Lung Congestion
8%
Lung Fluid
8%
Lung Vascular Resistance
6%
Mitral Insufficiency
9%
Odds Ratio
11%
Paroxysmal Atrial Fibrillation
6%
Percutaneous Aortic Valve Replacement
30%
Pulmonary Artery
7%
Pulmonary Hypertension
11%
Quality of Life
7%
Recurrent Disease
8%
Scoring System
9%
Sodium Zirconium Cyclosilicate
6%
Systolic Heart Failure
9%
Tolvaptan
20%
Ventricular Assist Device
29%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Failure
6%
Adverse Event
7%
Aortic Stenosis
6%
Aquaporin 2
6%
Argipressin
6%
Atrial Fibrillation
13%
Beta Adrenergic Receptor Blocking Agent
5%
Bosentan
7%
Brain Natriuretic Peptide
12%
Carvedilol
5%
Chick
7%
Chronic Kidney Failure
7%
Combination Therapy
14%
Congestive Heart Failure
100%
Creatinine
6%
Diuretic Agent
7%
Everolimus
5%
Heart Failure with Preserved Ejection Fraction
5%
Heart Failure with Reduced Ejection Fraction
5%
Heart Left Ventricle Failure
6%
Hyponatremia
6%
Inducible Nitric Oxide Synthase
5%
Inotropic Agent
5%
Ivabradine
5%
Landiolol
6%
Lung Congestion
7%
Messenger RNA
5%
Postmarketing Surveillance
6%
Pulmonary Hypertension
13%
Sodium Glucose Cotransporter 2 Inhibitor
7%
Systolic Heart Failure
7%
Tolvaptan
40%
Vasopressin
5%
